Lipoprotein distribution and composition in obesity: Their association with central adiposity

International Journal of Obesity

Volumn 21, Issue 12, 1997, Pages 1115-1120

  James, R W ^a   Brulhart Meynet, M C ^a   Lehmann, T ^a   Golay, A ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Cardiovascular disease; Central obesity; Lipoproteins; Triglycerides

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD SAMPLING; BODY FAT; BODY MASS; CARDIOVASCULAR DISEASE; DENSITY GRADIENT CENTRIFUGATION; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; SWITZERLAND; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0030727299     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800524     Document Type: Article

References (44)

1. Larsson B, Bjorntorp P, Tibblin G. The health consequences of moderate obesity. Int J Obes 1981; 5: 97-116.
2. Larsson B. Obesity, fat distribution and cardiovascular disease. Int J Obes (Suppl) 1991; 2: 53-57.
3. Donahue RP, Abbott RD, Bloom E, Reed DM, Yano K. Central obesity and coronary heart disease in men. Lancet 1987; 1: 821-824.
4. Bjorntorp P. Abdominal obesity and the development of noninsulin-dependent diabetes mellitus. Diabetes Metab Rev 1988; 4: 615-22.
5. Després JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis 1990; 10: 497-511.
6. Bjorntorp P. 'Portal' adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 1990; 10: 493-496.
7. Després J-P. Obesity and lipid metabolism: relevance of body fat distribution. Curr Opin Lipidol 1991; 2: 5-15.
8. Terry RB, Wood PD, Haskell WL, Stefanick ML, Krauss RM. Regional adiposity patterns in relation to lipids, lipoprotein cholesterol, and lipoprotein subtraction mass in men. J Clin Endocrinol Metab 1989; 68: 191-199.
9. Peeples LH, Carpenter JW, Israel RG, Barakat HA. Alterations in low-density lipoproteins in subjects with abdominal adiposity. Metabolism 1989; 38: 1029-1036.
10. Pouliot MC, Després JP, Nadeau A, Moorjani S, Prud'Homme D, Lupien PJ, Tremblay A, Bouchard C. Visceral obesity in men. Associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 1992; 41: 826-834.
11. Leenen R, van der Kooy K, Seidell JC, Deurenberg P. Visceral fat accumulation measured by magnetic resonance imaging in relation to serum lipids in obese men and women. Atherosclerosis 1992; 94: 171-181.
12. Zamboni M, Armellini F, Cominacini L, Turcato E, Todesco T, Bissoli L, Miccioli R, Bergamo-Andreis IA, Bosello O. Obesity and regional body-fat distribution in men: separate and joint relationships to glucose tolerance and plasma lipoproteins. Am J Clin Nutr 1994; 60: 682-687.
13. Deckelbaum RJ, Oschry Y, Rose L, Eisenberg S. Plasma triglyceride determines structure-composition in low and high-density lipoproteins. Arteriosclerosis 1984; 4: 225-231.
14. Griffin BA, Freeman DJ, Tait GW, Caslake MJ, Packard CJ, Shepherd J. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease. Atherosclerosis 1994; 106: 241-253.
15. Selby JV, Austin MA, Newman B, Zhang D, Quesebberry CP Jr, Mayer EJ, Krauss RM. LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation 1993; 88: 381-387.
16. Tan CE, Forster L, Caslake MJ, Beford D, Watson TD, McConnell M, Packard CJ, Shepherd J. Relations between plasma lipids and postheparin plasma lipases and VLDL and LDL subtraction patterns in normolipaemic men and women. Arterioscler Thromb Vasc Biol 1995; 15: 1839-1848.
17. Kissebah AH, Peiris AN, Evans DJ. Mechanisms associating body fat distribution to glucose intolerance and diabetes mellitus: window with a view. Acta Med Scand (Suppl) 1988; 723: 79-89.
18. Durnin JV, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 1974; 32: 77-97.
19. Lukaski HC. Methods for the assessment of human body composition: traditional and new. Am J Clin Nutr 1987; 46: 537-556.
20. Schutz Y, Bracco D. Impédance bioélectrique: utilité pour l'évaluation de la composition corporelle. Méd Hyg 1993; 51: 770-777.
21. Deurenberg P, Weststrate JA, Hautvast JG. Changes in fat-free mass during weight loss measured by bioelectrical impedance and by densitometry. Am J Clin Nutr 1989; 49: 33-36.
22. Teran JC, Sparks KE, Quinn LM, Fernandez BS, Krey SH, Steffee WP. Percent body fat in obese white females predicted by anthropometric measurements. Am J Clin Nutr 1991; 53: 7-13.
23. James RW, Pometta D. The distribution profiles of very low density and low density lipoproteins in poorly-controlled male, type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991; 34: 246-252.
24. Lindgren FT, Jensen LC, Hatch FT. The isolation and quantitative analysis of serum lipoproteins. In: Nelson GJ (ed.). Blood lipids and lipoproteins; quantisation, composition, and metabolism. Wiley-Interscience: New York, 1972, 181-274.
25. James RW, Pometta D. Differences in lipoprotein subfraction composition and distribution between type 1 diabetic men and control subjects. Diabetes 1990; 39: 1158-1164.
26. Groot PH, Scheck LM, Havekes L, van Noort WL, van't Hooft FM. A one-step separation of human serum high density lipoproteins 2 and 3 by rate-zonal density gradient ultracentrifugation in a swinging bucket rotor. J Lipid Res 1982; 23: 1342-1353.
27. James RW, Proudfoot A, Pometta D. Immunoaffinity fractionation of high density lipoprotein subclasses 2 and 3 using anti-apolipoprotein A-I and A-II immunosorbent gels. Biochim Biophys Acta 1989; 1002: 292-301.
28. Lowry OH, Rosebrough NJ, Fair AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
29. Després JP, Marette A. Relation of components of insulin resistance syndrome to coronary disease risk. Curr Opin Lipidol 1994; 5: 274-289.
30. James RW, Pometta D. Lipoprotein abnormalities in diabetes. In: Woodford FP, Davignon J, Sniderman A (eds). Atherosclerosis X. Elsevier: Amsterdam, 1995, pp 767-771.
31. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996; 3: 213-219.
32. Seidell JC, Bjorntorp P, Sjostrom L, Sannerstedt R, Krotkiewski M, Kvist H. Regional distribution of muscle and fat in men - new insight into the risk of abdominal obesity using computed tomography. Int J Obes 1989; 13: 289-303.
33. Lewis GF, Uffelman KD, Szeto LW, Steiner G. Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apo B production in normal weight and obese individuals. Diabetes 1993; 42: 833-842.
34. Lewis GF, Uffelman KD, Szeto LW, Weller B, Steiner G. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest 1995; 95: 158-166.
35. Eisenberg S, Gavish D, Oschry Y, Fainaru M, Deckelbaum RJ. Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment. J Clin Invest 1984; 74: 470-482.
36. McKeone BJ, Patsch JR, Pownall HJ. Plasma triglycerides determine low density lipoprotein composition, physical properties, and cell-specific binding in cultured cells. J Clin Invest 1993; 91: 1926-1933.
37. Bradley WA, Gianturco SH. Triglyceride-rich lipoproteins and atherosclerosis; pathophysiological considerations. J Intern Med (Suppl) 1994; 736: 33-39.
38. Austin MA, Krauss RM. Genetic control of low-density-lipoprotein subclasses. Lancet 1986; 2: 592-5.
39. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988; 260: 1917-1922.
40. Watts GF, Mandalia S, Brunt JN, Slavin BM, Coltart DJ, Lewis B. Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS). Metabolism 1993; 42: 1461-1467.
41. Zambon A, Austin MA, Brown BG, Hokanson JE, Brunzell JD. Effect of hepatic lipase on LDL in normal men and those with coronary artery disease. Arterioscler Thromb 1993; 13: 147-153.
42. Walton C, Lees B, Crook D, Worthington M, Godsland IF, Stevenson JC. Body fat distribution, rather than overall adiposity, influences serum lipids and lipoproteins in men independently of age. Am J Med 1995; 99: 459-464.
43. Kuksis A, Myher JJ, Geger K, Jones GJ, Breckenridge WC, Feather T, Hewitt D, Little JA. Decreased plasma phosphatidylcholine/free cholesterol ratio as an indicator of risk for ischemic vascular disease. Arteriosclerosis 1982; 2: 296-302.
44. Feingold KR. Importance of small intestine in diabetic hypercholesterolemia. Diabetes 1989; 38: 141-145.